NCT04435418View on ClinicalTrials.gov

Eliquis Acute Stroke Safety Evaluation

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
Ischemic StrokeTransient Ischemic AttackAtrial Fibrillation
Interventions
DRUG

Apixaban

The decision to treat with apixaban and the timing of initiation will be at the attending physicians' discretion, independent of enrolment in EASSE.

Trial Locations (1)

Unknown

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT04435418 - Eliquis Acute Stroke Safety Evaluation | Biotech Hunter | Biotech Hunter